Based in Paris and San Francisco, SpineGuard has been listed on NYSE Alternext since 29 April 2013, and its primary goal is to make spine surgery safer. Pierre Jérôme and Stéphane Bette founded the company in January 2009 to fully exploit the tremendous clinical and market potential for PediGuard®, the first handheld device capable of alerting surgeons in real time to potential pedicular or vertebral breaches. Several prominent clinical studies have established the reliability and accuracy of PediGuard for placing pedicle screws and have demonstrated a substantial reduction in medical teams’ exposure to X-rays and shorter operating times when the system is used.
April 2013: SpineGuard (ALSGD) successfully raised €8.3 million in an IPO.
Market capitalisation at IPO date: €31.4 million